Abstract
In eukaryotes, the manipulation of the host actin cytoskeleton is a necessary strategy for viral pathogens to invade host cells. Increasing evidence indicates that the actin homolog MreB of bacteria plays key roles in cell shape formation, cell polarity, cell wall biosynthesis and chromosome segregation. However, the role of bacterial MreB in the bacteriophage infection is not extensively investigated. To address this issue, in this study, the MreB of thermophilic Geobacillus sp. E263 from a deep-sea hydrothermal field was characterized by inhibiting the MreB polymerization and subsequently evaluating the bacteriophage GVE2 infection. The results showed that the host MreB played important roles in the bacteriophage infection at high temperature. After the host cells were treated with small molecule drug A22 or MP265, the specific inhibitors of MreB polymerization, the adsorption of GVE2 and the replication of GVE2 genome were significantly repressed. The confocal microscopy data revealed that MreB facilitated the GVE2 infection by inducing the polar distribution of virions during the phage infection. Our study contributed novel information to understand the molecular events of the host in response to bacteriophage challenge and extended our knowledge about the host-virus interaction in deep-sea vent ecosystems.
Similar content being viewed by others
Introduction
In most rod-shaped bacteria, the bacterial MreB, a homolog of actin1, is employed in maintaining their morphology and guiding the peptidoglycan synthesis during elongation2,3,4,5. Gram-negative bacteria, such as Escherichia coli and Caulobacter crescentus, produce only a single form of MreB, whereas gram-positive bacteria such as Bacillus subtilis have multiple MreB-like proteins (Mbl and MreBH)1,6,7. Mutational analyses have provided accumulating evidence that MreB plays key roles in cell shape formation, cell polarity, cell wall biosynthesis and chromosome segregation1,6,7,8,9,10,11,12,13,14. As visualized by fluorescence microscopy, MreB proteins have been reported to form spiral-like filamentous structures along the rod-shaped cells, underneath the cytoplasmic membrane1,3,6,7,11,15,16,17,18,19. Many studies have suggested that MreB helices act as a scaffold for proteins involved in cell wall biosynthesis, cell elongation and chromosome segregation1,5,6,10,11,17,20. However, some recent reports using high-resolution imaging indicate that either in E. coli or in B. subtilis MreB filaments do not run the length of the cell21,22. Instead, they are actually composed of small dynamic patches that move around the cell circumference and are driven by the cell wall synthesis machinery4,7,21,22,23,24,25.
As reported, when the filament formation of MreB is blocked by a specific drug A22 [S-(3,4-dichlorobenzyl) isothiourea]26, the bacterial cells lose their rod shape and transform into spherical morphology1,3,4,7,11,20,26,27,28,29. Then a downstream abrogation in penicillin-binding protein (PBP) localization and peptidoglycan (PG) synthesis patterns can be observed1,30. The round-shaped cells finally die unless their growth conditions are changed7. For example, media with high concentrations of Mg2+ allow the normal growth of B. subtilis MreB mutant17,31. Considering the toxicity and indirectness of A22, a new drug named MP265 (4-chlorobenzyl chloride) is used as an MreB inhibitor in recent studies32.
In eukaryotic cells, actin is crucial to many important cellular processes such as cell division, uptake of extracellular material and intracellular transport33,34. Thus many pathogens, including viruses, have evolved to utilize host actin cytoskeleton during infection33,34. Because MreB is a prokaryotic homolog of actin, it is plausible that bacteriophages would take advantage of the host's MreB cytoskeleton during the virus infection. The main life cycle of bacteriophage contains several steps, including adsorption, DNA injection, metabolism transition, DNA replication, phage morphogenesis, package and lysis of the host35. It is documented that the B. subtilis MreB is involved in the DNA replication of bacteriophage phi 296,36. However, the role of cytoskeletal protein MreB in other steps of phage infection has not extensively investigated. In particular, the MreB protein has not been characterized in the phage infection of thermophiles.
In deep-sea hydrothermal vents, thermophiles comprise the basis of the food chain of these deep-sea ecosystems37. It is believed that the most significant players in deep-sea hydrothermal vents are thermophilic viruses including archaeal viruses and bacteriophages. Viruses may be the major causes of vent thermophile mortality37,38,39.
To reveal the role of MreB in the infection of thermophilic bacteriophage GVE2 in its host Geobacillus sp. E263, a gram-positive thermophile from a deep-sea hydrothermal field40, the polymerization of MreB protein was inhibited and then the phage infection was evaluated. The results showed that the host MreB played an essential role in the adsorption of GVE2 and the replication of its genome in a high temperature environment.
Results
Effects of MreB on GVE2 infection
To characterize the role of MreB in the GVE2 infection, the MreB gene was cloned from Geobacillus sp. E263. The results showed that the E263 strain contained MreB gene (Fig. 1A), the sequence of which was highly conserved with that of mesophilic bacteria (data not shown), suggesting that MreB in thermophiles shared similar/same functions as that in mosephilic bacteria. In mosephilic bacteria, it is reported that the filament formation of MreB could be inhibited by A22 or MP26526,32. Therefore the MreB-specific drugs A22 and MP265 were used to inhibit the polymerization of MreB in Geobacillussp. E263 cells. The confocal microscopy data presented that the thermostable MreB-GFP was distributed in Geobacillussp. E263 cells as helical structures, while the GFP alone showed no helix (Fig. 1B). When A22 or MP265 was presented, the MreB-GFP could not form the helical conformation (Fig. 1B). The results indicated that both of A22 and MP265 could inhibit the MreB polymerization in thermophiles as in mosephilic bacteria. As assayed, the optimal concentrations of A22 and MP265 were 40 μg/m and 70 μg/ml, respectively.
The GVE2 virions were purified and observed to show the characteristic shape of Siphoviridae bacteriophage (Fig. 1C). Then the E263 cells were treated with A22 or MP265 and subsequently infected with the purified GVE2 at high temperature (60°C), followed by turbidity assays and plaque assays to evaluate the effects of MreB on the GVE2 infection. The results indicated that the addition of GVE2 led to a significant decrease of E263 growth rate due to the lysis ability of bacteriophage as evidenced by lower turbidity values and more plaques in samples incubated with the phage (Fig. 1D and 1E). However, the A22-treated and GVE2-infected host cells (E263 + GVE2 + A22) grew normally, showing that the inhibition of MreB polymerization by A22 resulted in inefficient GVE2 infection. When the A22 in the A22-treated bacteria was removed and the bacteria were simultaneously infected with GVE2 [E263 + GVE2 + A22 (removed)], the turbidity values and plaques of the bacteria significantly decreased, suggesting that MreB was no longer inactive and that phage infection could proceed (Fig. 1D and 1E). The MP265 yielded the same results as A22 (Fig. 1D and 1E). The data presented that MreB played an essential role in the bacteriophage infection at high temperature and that this role could be withdrawn by addition of A22 or MP265.
Roles of MreB in adsorption and replication of GVE2
In an attempt to reveal the roles of MreB in GVE2 infection, the adsorption of GVE2 and replication of GVE2 genome were evaluated. In the GVE2 adsorption analysis, the MOI of GVE2 virions was 0.01. The results indicated that the copies of the free phages (phages not absorbed on E263 cell surfaces) were significantly increased in the A22-treated and GVE2-infected E263 cells (E263 + GVE2 + A22) at 15 min onwards post-infection of GVE2 (Fig. 2A). The results showed that MreB played an important role in the absorption of GVE2 during virus infection. When A22 in the A22-treated bacteria was removed [E263 + GVE2 + A22 (removed)], the number of copies of free phages in this treatment was not significantly different from that in the positive control GVE2 only (Fig. 2A). The data supported the conclusion that MreB was required for the adsorption of GVE2 in the host cells.
It was found that when the MreB polymerization was inhibited by A22, the GVE2 genome copy numbers were significantly lower than those in samples with GVE2 only (Fig. 2B), indicating the importance of MreB in the GVE2 genome replication. The results revealed that the recovery of MreB polymerization by removal of A22 led to significant increases of GVE2 genome copies (Fig. 2B). One-step growth curve assays showed that the number of plaques was significantly decreased for the treatment E263 + GVE2 + A22 compared with those of the treatments E263 + GVE2 and E263 + GVE2 + A22 (removed) (Fig. 2C), indicating that MreB might play essential roles in the GVE2 genome replication, particle assembly and host cell lysis. As assayed, MP265 yielded the similar results as A22 (Fig. 2A, B and C).
Effects of MreB on the localization of GVE2 virions in host cells during GVE2 infection
In order to characterize the effects of MreB on the distribution of GVE2 virions in host cells during phage infection, the A22-treated or MP265-treated E263 cells were infected with GVE2, followed by examination with confocal microscopy. The results showed that when the MreB polymerization was inhibited by A22 or MP265, the rod-shaped bacterial cells were changed into spherical cells (Fig. 3A). However, the removal of the drug led to the recovery of bacterial cell shape (Fig. 3A). The data indicated the essential role of the MreB polymerization in cell morphological change of bacteria. It was revealed that the morphological change of host cells led to the change of the GVE2 distribution in host cells during phage infection (Fig. 3B). GVE2 virions preferred to localize in the cell poles of its host at the early stage of infection. However, the virions were distributed around the host cells when the MreB polymerization was inhibited by A22 or MP265 (Fig. 3B). As controls, the samples were labeled with anti-GST antibody and no signal was observed (data not shown). These results indicated that the cytoskeleton protein MreB, required for the morphology of bacteria, affected the distribution of phage in host cells during phage infection.
Confocal microscopy data revealed that the percentage of GVE2-infected host cells was significantly decreased in the treatment E263 + GVE2 + A22 compared with that of the treatment E263 + GVE2 (Fig. 3C). The findings suggested that the polymerized MreB could facilitate the GVE2 infection by affecting the distribution of virions during the phage infection.
To evaluate the colocalization of MreB and GVE2, the thermostable MreB-GFP fusion protein was overexpressed in GVE2-infected E263 cells. The results revealed that the MreB-GFP was colocalized with GVE2 during the phage infection, while the controls presented no colocalization of GFP and GVE2 (Fig. 3D), suggesting that the polymerization of MreB benefited the infection of GVE2. To determine the direct involvement of MreB in the polar localization of the GVE2 virions, the MreB-GFP -overexpressed E263 cells were treated with A22 or MP265, followed by infection with GVE2. The confocal microscopy results revealed that MreB-GFP was colocalized with the GVE2 virions and was distributed around the cells in the presence of A22 or MP265 (Fig. 3E). In this case, the GVE2 virions were not localized in the cell poles of its host (Fig. 3E), suggesting that MreB was directly involved in the polar localization of the virions. Collectively, these findings indicated that MreB played an essential role in the phage infection by direct interaction with the phage.
Discussion
Most studies on the interaction between virus and cell cytoskeleton protein come from eukaryotes. Viruses have evolved several ways to exploit the host actin cytoskeleton by using its essential functions in eukaryotic cells, in particular, the uptake and short-range intracellular transport33,34.
At present, homologues of at least three eukaryotic cytoskeletal protein families (actin, tubulin and intermediate filaments) have been characterized in bacteria6,15. Phages have co-evolved with their host bacteria, thus, it's not surprising that bacteriophages can take advantage of their host's MreB cytoskeletal systems, which are known scaffolds for some key processes of bacterial cells6. It is believed that viruses exploit host actin to invade their hosts in eukaryotes6,41,42. In bacteria, however, the roles of cytoskeletal protein MreB in phage-bacterium interactions have not been extensively investigated. Our study showed that during the GVE2 infection the host MreB was required for the adsorption of phage and the replication of phage genome in the host cells.
Adsorption of bacteriophage, the first step of phage infection process, involves the recognition and contact of phage with the host cell surface. In general, adsorption of phage occurs in two steps, a reversible step and a subsequent irreversible binding step43. The first contact of phage with its host cell surface is usually reversible binding. So the reversible step allows for the dissociation of phage from its host. Subsequently, the phage attaches irreversibly to specific receptors on the host cell surface, leading to the injection of the phage genome from its capsid into the host cell. Although DNA injection and irreversible adsorption has been characterized, it is still contentious43,44. Phage adsorption to its host cell surface needs a specific interaction between the phage tail proteins and host receptors45. Receptors are exposed in the outer membrane of Gram-negative bacteria and in the thick peptidoglycan cell wall of Gram-positive bacteria45. Phage adsorption to Gram-positive bacteria is still poorly understood. It has been reported that the teichoic acid in the bacterial cell wall is essential for reversible binding of several phages in Bacillus subtilis, such as phi 29, phi 25 and SPP143.
Our study revealed that the host bacterial MreB was involved in the replication of GVE2 genome in host cells in high temperature environment. The cytoskeleton protein MreB might function as a primary organizer of the phage DNA replication because phage DNA and replication machinery components distributed in helical structures in a MreB-dependent way6. As well known, the gene konck-out strategy is conventionally employed to investigate the function of a gene. However, the molecular biology of thermophiles is not intensively investigated, resulting in the lack of gene knock-out system, gene overexpression system and protein labeling platforms at high temperature. To reveal the role of MreB in the phage infection, the gene knock-out strategy was conducted, but it was not successfully carried out in this study, suggesting that the deficit of the MreB might be lethal for the thermophiles. These issues merit to be further investigated. In this context, the requirement of host MreB in the phage infection process resulted from the involvement of MreB in the adsorption and replication of GVE2 in its host cells.
During the infection process, bacteriophages bind preferentially to host cell poles in some Gram-negative and Gram-positive bacteria44,46. For example, phage lambda needs a polar localized inner membrane protein ManY to help the injection of phage genomic DNA. Therefore, it usually shows a polar adsorption at low multiplicities of infection44,46. In the case of phage SPP1, both reversible adsorption step and irreversible binding to YueB occur preferentially near the cell poles, which are related to the initiation of DNA replication44,47. It is evident that the MreB protein is involved in the pole targeting of phage in bacterial cells48. In our study, the confocal microscopic images revealed that MreB played an important role in the polar distribution of phage in host cells. The MreB polymerization was required to keep the morphology of bacterial cells and the polymerized MreB facilitated the phage infection.
This study indicated that MreB was an essential factor in both adsorption of GVE2 and replication of GVE2 genome. However, the mechanism of those processes and the detailed role of MreB in GVE2 infection are still unknown. The molecular events in bacteriophage infection process in high temperature environment need to be characterized in future. Thermophiles, the basis of the food chain in deep-sea hydrothermal vent, power the vent biological communities with the source of energy. In the vent ecosystem, the most significant players in nutrient and energy cycling are thermophilic viruses36,49,50. Our findings provided insights into the interaction between bacteriophage and host thermophile in high temperature environment. This would be helpful to reveal roles of bacteriophages in controlling bacteria population and carbon turnover in deep-sea hydrothermal vent ecosystems.
Methods
Infection of Geobacillus sp. E263 by GVE2 and purification of GVE2 virions
The deep-sea thermophile Geobacillus sp. E263 and its thermophilic bacteriophage GVE2 were isolated in our previous studies37,40. The host E263 was cultured at 60°C in TTM medium (0.2% NaCl, 0.4% yeast extract, 0.8% tryptone; pH 7.0) supplemented with 25 mM MgSO417,31. The host strain cultures in the mid log phase (OD600 = 0.4) were infected with GVE2 at a multiplicity of infection (MOI) of 0.01, 0.5 or 5.
The GVE2 virions were purified as described previously37. Virus samples were examined under a transmission electron microscope (JEOL 100 CXII) for purity.
Dosages of the MreB inhibitors
To determine the dosages of the MreB inhibitor, A22 [S-(3,4-dichlorobenzyl) isothiourea, Merck, Germany] or MP265 (4-chlorobenzyl chloride, Alfa Aesar, USA) with different concentrations (0.1–100 μg/ml) were mixed with cultures of E263 at the mid log phase (OD600 = 0.4). At different time after A22 or MP265 inoculation, the bacteria were collected and examined by microscopy to evaluate the optimal dosages.
Turbidity assay
To assess the infection of E263 cells by GVE2, a turbidity assay was performed as previously described37. E263 cells were cultured at 60°C. When the OD600 of the cultured bacteria was 0.3, the bacteria were mixed with A22 (final concentration 40 μg/ml) or MP265 (final concentration 70 μg/ml). Ten minutes later, the bacteria were infected with the purified GVE2 virions at a MOI of 5. To evaluate the effects of the removal of A22 or MP265 in the A22-treated bacteria or the MP265-treated bacteria on the GVE2 infection, the bacteria of the treatment E263 + GVE2 + A22 (removed) or E263 + GVE2 + MP265 (removed) were cultured for 1 h after the GVE2 infection and then centrifuged at 18,000 × g for 5 min to remove A22 or MP265. Subsequently the pelleted bacteria were resuspended and cultured in fresh TTM medium. At different times after the culture of E263, the optical densities (OD600) of all treatments were measured by spectrophotometer (UV-1700 Shimadzu Corporation, Japan). The experiments were repeated three times.
Plaque assay
The E263 cultures (OD600 = 0.4) were mixed with A22 (40 μg/ml) or MP265 (70 μg/ml) and then incubated for 30 min. Then the bacteria were mixed with GVE2 virions at an MOI of 0.5 and subsequent with TTM soft agar medium (TTM medium with 0.5% agar). The soft media were spread on TTM solid medium plate, followed by incubation at 60°C overnight. For the treatment E263 + GVE2 + A22 or E263 + GVE2 + MP265, A22 or MP265 was dissolved in the TTM soft agar medium. For the treatment E263 + GVE2 + A22 (removed) or E263 + GVE2 + MP265 (removed), there was no A22 or MP265 in the TTM soft agar medium. Finally the plaques were examined.
GVE2 adsorption assay
E263 cultures at OD600 of 0.4 were supplemented with 10 mM CaCl2 and 15 mM MnCl2 at 60°C. At the same time, 40 μg/ml of A22 or 70 μg/ml of MP265 was added into the cultures. After culture of E263 for 30 min, the bacterial cells were collected and infected with purified GVE2 virions at an MOI of 0.01. For the treatment E263 + GVE2 + A22 (removed), A22 was removed 30 min after addition of A22 (as described above). The treatment E263 + GVE2 + MP265 (removed) was carried out accordingly. Then the cells were infected with GVE2. At different time postinfection, the bacteria were collected. After 5 s of vortex, the bacteria were incubated for 5 min at room temperature and then centrifuged at 15,000 × g for 5 min. The supernatant was subjected to quantitative real-time PCR to detect the free (non-adsorbed) phages.
GVE2 replication analysis
Cells of E263 at OD600 of 0.3 were infected with purified GVE2 virions at a MOI of 5. After culture at 60°C for 30 min, the cells were mixed with 40 μg/ml of A22 or 70 μg/ml of MP265. For the treatment E263 + GVE2 + A22 (removed) or E263 + GVE2 + MP265 (removed), A22 or MP265 was removed at 30 min after addition of A22 or MP265 as described above. The treated bacteria were collected at different times postinfection, vortexed for 5 s, lysed for 20 min at 99°C and centrifuged for 10 s. The supernatant was subjected to quantitative real-time PCR for the detection of GVE2 genome copies. The experiments were conducted three times.
One-step growth curve of GVE2
The E263 cells were suspended in 800 μl of fresh TTM medium and then incubated with GVE2 at an MOI of 0.5 for 30 min at 4°C. Subsequently 10 μl of the antibody against VP371 (a capsid protein of GVE2) was added to terminate the adsorption. The mixture was centrifuged at 12,000 × g for 10 min and the pellets containing the GVE2-infected cells were resuspended in 20 ml of TTM medium. The bacteria were mixed with A22 (40 μg/ml) or MP265 (70 μg/ml) and incubated for 10 min at room temperature. For the treatment E263 + GVE2 + A22 (removed) or E263 + GVE2 + MP265 (removed), the bacteria were washed with TTM media by centrifugation at 1,000 × g to remove A22 or MP265. All the above bacteria were cultured at 60°C. At different time after culture, the bacteria were subjected to plaque assays. The experiments were biologically repeated three times.
Quantitative real-time PCR
Real-time PCR was conducted to quantify the GVE2 genome copies in cell lysate using GVE2-specific primers (5′-ATCGGTTGTACTAACTTAAC-3′ and 5′-GCTTG TCGTATTCCTTATC-3′) and GVE2-specific TaqMan fluorogenic probe (5′-FAM CC GTCTTGTTCGTTGTCTCTGC-Eclipse-3′). The genomic DNA of GVE2 was collected from the GVE2-infected Geobacillus sp. E263 samples by heating at 99°C for 20 min. The real-time PCR was conducted as described previously51.
Protein recombinant expression in E. coli, antibody preparation and ntibody labeling
Protein recombinant expression, antibody preparation and antibody labeling were carried out as before37. Briefly the vp371 gene of GVE252 was cloned into pGEX-4T-2 vector (Novagen, Germany) and expressed in E. coli BL21 (DE3) as a glutathione S-transferase (GST)-tagged fusion protein. The recombinant VP371 protein was used as an antigen to immunize mice. The immunoglobulin G (IgG) fraction of the antiserum was purified with protein A-Sepharose (Bio-Rad, USA) and stored at −80°C until use. As determined by enzyme-linked immunosorbent assay, the antiserum titer was 1:10,000. The specificity of antibody was confirmed using Western blotting with the recombinant protein. Then the antibody labeling was conducted to label the antibody using fluorescent dyes37.
Phase contrast microscopy
E263 cells at exponential growth phase were treated with 40 μg/ml of A22 or 70 μg/ml of MP265. At 30 min after the addition of the drug, E263 cells were harvested by centrifugation at 1000 × g for 1 min. Subsequently the A22-treated, MP265-treated and drug-free E263 cells were examined with a phase contrast microscopy (Nikon, Japan).
Immunofluorescence microscopy
Overnight cultures of E263 were diluted with TTM medium containing 0.01 M MgCl2 at 1:100 and then grown at 60°C. When the OD600 of bacteria reached 0.3, the bacteria were treated with 40 μg/ml of A22 or 70 μg/ml of MP265. After culture for 30 min, the cells were infected with GVE2 at an MOI of 5. At different times post-infection, the GVE2-infected bacteria were collected. For imaging, the E263 cells were immobilized with methanol for 30 min at 4°C. Then the labeled anti-VP371 or anti-GST antibody was added to the immobilized cells that were permeabilized by acetone (30 min, 4°C) and the cells were incubated overnight at 4°C. The cells were labeled with 10 μg/ml of 4′, 6-diamidino-2-phenylindole (DAPI) (Invitrogen) for 10 min. Subsequently 10 μl of samples were dripped on slides (Sigma, USA) covered with a thin 1% agarose film and examined under a Leica TCS SP5 confocal microscope (Germany). The digital images were acquired by and analyzed using LAS AF version 2.0.0 software.
Effects of A22 and MP265 on the MreB polymerization
In order to elucidate the effects of A22 and MP265 on the MreB polymerization, a thermosensitive sgsE promoter51, a thermostable GFP gene (Los Alamos National Laboratory, USA) and the MreB gene of E263 were cloned into the pNW33N vector (Bacillus Genetic Stock Center, USA) to make the pNW33N-sgsEp-MreB-GFP construct. Then the E263 cells were transformed with the plasmid and cultured at 65°C. E263 cells at exponential growth phase were treated with 40 μg/ml of A22 or 70 μg/ml of MP265 for 30 min. After immobilization with methaol for 30 min, the drug-treated and drug-free E263 cells were examined with a Leica TCS SP5 confocal microscope (Germany).
Colocalization of MreB and GVE2
The E263 cells were transformed with the pNW33N-sgsEp-MreB-GFP plasmid and cultured at 65°C. Overnight culture of E263 harboring MreB-GFP was diluted with TTM medium at 100 folds and continued to grow at 65°C. When the OD600 reached 0.6, the bacteria were infected with purified GVE2 at an MOI of 5. At different times, the bacteria were collected and the GVE2 virions were labeled with the anti-VP371 antibody as described above. Subsequently the bacteria were examined under a Leica TCS SP5 confocal microscope (Germany).
Statistical analysis
The numerical data from three independent experiments were analyzed by one-way analysis of variance (ANOVA) to calculate the mean and standard deviation (SD) of the triplicate assays.
References
White, C. L. & Gober, J. W. MreB: pilot or passenger of cell wall synthesis? Trends Microbiol 20, 74–79 (2012).
Cabeen, M. T. & Jacobs-Wagner, C. Bacterial cell shape. Nat Rev Microbiol 3, 601–610 (2005).
Gitai, Z., Dye, N. & Shapiro, L. An actin-like gene can determine cell polarity in bacteria. Proc Natl Acad Sci U S A 101, 8643–8648 (2004).
Typas, A., Banzhaf, M., Gross, C. A. & Vollmer, W. From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat Rev Microbiol 10, 123–136 (2012).
Wang, S., Furchtgott, L., Huang, K. C. & Shaevitz, J. W. Helical insertion of peptidoglycan produces chiral ordering of the bacterial cell wall. Proc Natl Acad Sci U S A 109, E595–604 (2012).
Munoz-Espin, D. et al. The actin-like MreB cytoskeleton organizes viral DNA replication in bacteria. Proc Natl Acad Sci U S A 106, 13347–13352 (2009).
Salje, J., van den Ent, F., de Boer, P. & Lowe, J. Direct membrane binding by bacterial actin MreB. Mol Cell 43, 478–487 (2011).
Carballido-Lopez, R. Orchestrating bacterial cell morphogenesis. Mol Microbiol 60, 815–819 (2006).
Carballido-Lopez, R. et al. Actin homolog MreBH governs cell morphogenesis by localization of the cell wall hydrolase LytE. Dev Cell 11, 399–409 (2006).
Daniel, R. A. & Errington, J. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113, 767–776 (2003).
Figge, R. M., Divakaruni, A. V. & Gober, J. W. MreB, the cell shape-determining bacterial actin homologue, co-ordinates cell wall morphogenesis in Caulobacter crescentus. Mol Microbiol 51, 1321–1332 (2004).
Gitai, Z. The new bacterial cell biology: moving parts and subcellular architecture. Cell 120, 577–586 (2005).
Madabhushi, R. & Marians, K. J. Actin homolog MreB affects chromosome segregation by regulating topoisomerase IV in Escherichia coli. Mol Cell 33, 171–180 (2009).
Shih, Y. L. & Rothfield, L. The bacterial cytoskeleton. Microbiol Mol Biol Rev 70, 729–754 (2006).
Carballido-Lopez, R. The bacterial actin-like cytoskeleton. Microbiol Mol Biol Rev 70, 888–909 (2006).
Carballido-Lopez, R. & Errington, J. The bacterial cytoskeleton: in vivo dynamics of the actin-like protein Mbl of Bacillus subtilis. Dev Cell 4, 19–28 (2003).
Scheffers, D. J. & Pinho, M. G. Bacterial cell wall synthesis: new insights from localization studies. Microbiol Mol Biol Rev 69, 585–607 (2005).
Slovak, P. M., Wadhams, G. H. & Armitage, J. P. Localization of MreB in Rhodobacter sphaeroides under conditions causing changes in cell shape and membrane structure. J Bacteriol 187, 54–64 (2005).
Vats, P. & Rothfield, L. Duplication and segregation of the actin (MreB) cytoskeleton during the prokaryotic cell cycle. Proc Natl Acad Sci U S A 104, 17795–17800 (2007).
Kruse, T., Bork-Jensen, J. & Gerdes, K. The morphogenetic MreBCD proteins of Escherichia coli form an essential membrane-bound complex. Mol Microbiol 55, 78–89 (2005).
Swulius, M. T. et al. Long helical filaments are not seen encircling cells in electron cryotomograms of rod-shaped bacteria. Biochem Biophys Res Commun 407, 650–655 (2011).
Swulius, M. T. & Jensen, G. J. The helical MreB cytoskeleton in Escherichia coli MC1000/pLE7 is an artifact of the N-Terminal yellow fluorescent protein tag. J Bacteriol 194, 6382–6386 (2012).
Dominguez-Escobar, J. et al. Processive movement of MreB-associated cell wall biosynthetic complexes in bacteria. Science 333, 225–228 (2011).
Garner, E. C. et al. Coupled, circumferential motions of the cell wall synthesis machinery and MreB filaments in B. subtilis. Science 333, 222–225 (2011).
van Teeffelen, S. et al. The bacterial actin MreB rotates and rotation depends on cell-wall assembly. Proc Natl Acad Sci U S A 108, 15822–15827 (2011).
Iwai, N., Nagai, K. & Wachi, M. Novel S-benzylisothiourea compound that induces spherical cells in Escherichia coli probably by acting on a rod-shape-determining protein(s) other than penicillin-binding protein 2. Biosci Biotechnol Biochem 66, 2658–2662 (2002).
Dye, N. A., Pincus, Z., Fisher, I. C., Shapiro, L. & Theriot, J. A. Mutations in the nucleotide binding pocket of MreB can alter cell curvature and polar morphology in Caulobacter. Mol Microbiol 81, 368–394 (2011).
Bendezu, F. O. & de Boer, P. A. Conditional lethality, division defects, membrane involution and endocytosis in mre and mrd shape mutants of Escherichia coli. J Bacteriol 190, 1792–1811 (2008).
Lee, J. C., Cha, J. H., Zerbv, D. B. & Stewart, G. C. Heterospecific expression of the Bacillus subtilis cell shape determination genes mreBCD in Escherichia coli. Curr Microbiol 47, 146–152 (2003).
Dye, N. A., Pincus, Z., Theriot, J. A., Shapiro, L. & Gitai, Z. Two independent spiral structures control cell shape in Caulobacter. Proc Natl Acad Sci U S A 102, 18608–18613 (2005).
Formstone, A. & Errington, J. A magnesium-dependent mreB null mutant: implications for the role of mreB in Bacillus subtilis. Mol Microbiol 55, 1646–1657 (2005).
Takacs, C. N. et al. MreB drives de novo rod morphogenesis in Caulobacter crescentus via remodeling of the cell wall. J Bacteriol 192, 1671–1684 (2010).
Roberts, K. L. & Baines, J. D. Actin in herpesvirus infection. Viruses 3, 336–346 (2011).
Taylor, M. P., Koyuncu, O. O. & Enquist, L. W. Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 9, 427–439 (2011).
Roucourt, B. & Lavigne, R. The role of interactions between phage and bacterial proteins within the infected cell: a diverse and puzzling interactome. Environ Microbiol 11, 2789–2805 (2009).
Munoz-Espin, D., Holguera, I., Ballesteros-Plaza, D., Carballido-Lopez, R. & Salas, M. Viral terminal protein directs early organization of phage DNA replication at the bacterial nucleoid. Proc Natl Acad Sci U S A 107, 16548–16553 (2010).
Wei, D. & Zhang, X. Proteomic analysis of interactions between a deep-sea thermophilic bacteriophage and its host at high temperature. J Virol 84, 2365–2373 (2010).
Anderson, R. E., Brazelton, W. J. & Baross, J. A. Is the genetic landscape of the deep subsurface biosphere affected by viruses? Front Microbiol 2, 219 (2011).
Anderson, R. E., Brazelton, W. J. & Baross, J. A. Using CRISPRs as a metagenomic tool to identify microbial hosts of a diffuse flow hydrothermal vent viral assemblage. FEMS Microbiol Ecol 77, 120–133 (2011).
Liu, B., Wu, S., Song, Q., Zhang, X. & Xie, L. Two novel bacteriophages of thermophilic bacteria isolated from deep-sea hydrothermal fields. Curr Microbiol 53, (2006).
Greber, U. F. & Way, M. A superhighway to virus infection. Cell 124, 741–754 (2006).
Yang, G., Xiao, X., Yin, D. & Zhang, X. The interaction between viral protein and host actin facilitates the virus infection to host. Gene 507, 139–145 (2012).
Sao-Jose, C., Baptista, C. & Santos, M. A. Bacillus subtilis operon encoding a membrane receptor for bacteriophage SPP1. J Bacteriol 186, 8337–8346 (2004).
Jakutyte, L. et al. Bacteriophage infection in rod-shaped gram-positive bacteria: evidence for a preferential polar route for phage SPP1 entry in Bacillus subtilis. J Bacteriol 193, 4893–4903 (2011).
Sao-Jose, C. et al. The ectodomain of the viral receptor YueB forms a fiber that triggers ejection of bacteriophage SPP1 DNA. J Biol Chem 281, 11464–11470 (2006).
Edgar, R. et al. Bacteriophage infection is targeted to cellular poles. Mol Microbiol 68, 1107–1116 (2008).
Baptista, C., Santos, M. A. & Sao-Jose, C. Phage SPP1 reversible adsorption to Bacillus subtilis cell wall teichoic acids accelerates virus recognition of membrane receptor YueB. J Bacteriol 190, 4989–4996 (2008).
Rokney, A. et al. E. coli transports aggregated proteins to the poles by a specific and energy-dependent process. J Mol Biol 392, 589–601 (2009).
Suttle, C. A. Viruses in the sea. Nature 437, 356–361 (2005).
Suttle, C. A. Marine viruses-major players in the global ecosystem. Nat Rev Microbiol 5, 801–812 (2007).
Jin, M., Ye, T. & Zhang, X. Roles of bacteriophage GVE2 endolysin in host lysis at high temperatures. Microbiology 159, 1597–1605 (2013).
Liu, B. & Zhang, X. Deep-sea thermophilic Geobacillus bacteriophage GVE2 transcriptional profile and proteomic characterization of virions. Appl Microbiol Biotechnol 80, 697–707 (2008).
Acknowledgements
This work was financially supported by National Natural Science Foundation of China (41276152), China Ocean Mineral Resources R & D Association (DY125-15-E-01) and Hi-Tech Research and Development Program of China (2012AA092103-5).
Author information
Authors and Affiliations
Contributions
M.J., Y.C. and C.X. performed the experiments under the supervision of X.Z., M.J. and Y.C. wrote the manuscript. All authors reviewed the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images in this article are included in the article's Creative Commons license, unless indicated otherwise in the image credit; if the image is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the image. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
About this article
Cite this article
Jin, M., Chen, Y., Xu, C. et al. The effect of inhibition of host MreB on the infection of thermophilic phage GVE2 in high temperature environment. Sci Rep 4, 4823 (2014). https://doi.org/10.1038/srep04823
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep04823
This article is cited by
-
Natural transformation occurs independently of the essential actin-like MreB cytoskeleton in Legionella pneumophila
Scientific Reports (2015)
-
The effect of tryptophol on the bacteriophage infection in high-temperature environment
Applied Microbiology and Biotechnology (2015)
-
Identification and characterization of a novel Geobacillus thermoglucosidasius bacteriophage, GVE3
Archives of Virology (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.